Therma Bright Announces up to $1,000,000 Private Placement Financing with Insider Participation and Debt Settlements
Toronto, Ontario--(Newsfile Corp. - July 20, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it proposes to undertake a non-brokered private placement (the "Private Placement") of up to 13,333,334 units ("Units") at a price of $0.075 per Unit for proceeds of $1,000,000 if the Private Placement is fully subscribed. Each Unit will consist of one common share of the Company and one-half (0.5) of one...
2020-07-20 6:00 AM EDT
Therma Bright Provides Update on Orpheus Medica Rapid Test for COVID-19 Virus in Saliva - CoviSafe(TM)
Toronto, Ontario--(Newsfile Corp. - July 16, 2020) - Therma Bright Inc. (TSXV: THRM), ("Therma" or the "Company"), a progressive medical device technology company, is pleased to provide an update on its project with Orpheus Medica to develop a rapid test to detect COVID-19 virus in saliva - the CoviSafeTM. The project will integrate Orpheus' novel biologics platform, coupled with third party rapid detection and portable device technology, to develop a reliable palm-sized test for screening of...
2020-07-16 6:33 AM EDT
Therma Bright Completes Due Diligence to Acquire Medical Device Technology from Saringer Life Science Technologies Inc.
Toronto, Ontario--(Newsfile Corp. - July 9, 2020) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, is pleased to announce that it has completed due diligence and will move forward with closing of the asset purchase transaction with Saringer Life Science Technologies Inc. ("Saringer"). As previously reported on January 15, 2020 and April 8th, 2020, the Company entered a non-binding letter of intent ("LOI") to acquire...
2020-07-09 7:15 AM EDT
Therma Bright Enters Into a Binding Letter of Intent with Orpheus Medica to Develop a Rapid Test to Detect COVID-19 Virus in Saliva
Toronto, Ontario--(Newsfile Corp. - July 7, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has entered into a binding letter of intent with Orpheus Medica Inc. ("Orpheus") to partner in the development of a rapid saliva test for the detection of the virus (SARS-CoV-2) causing COVID-19. Therma will provide funding for the project in phases ("Phase" or "Phases") as certain milestones are...
2020-07-07 6:00 AM EDT
Therma Bright Initiates Due Diligence to Manufacture Personal Protective Equipment, Hand Sanitizers and Applies for Government Grants
Toronto, Ontario--(Newsfile Corp. - May 11, 2020) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, has initiated due diligence and has applied for government grants to manufacture personal protective equipment ("PPE") and hand sanitizers to combat the Covid-19 crisis. Several potential partners have approached Therma Bright to produce PPE and hand sanitizers for the Canadian and export markets. Therma Bright is ideally...
2020-05-11 4:35 PM EDT
Therma Bright Extends Closing to Acquire Benepod(R) Pain Relief Technology and Other Medical Device Technology from Saringer Life Science Technologies Inc.
Toronto, Ontario--(Newsfile Corp. - April 8, 2020) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, has agreed to extend the closing of the asset purchase transaction with Saringer Life Science Technologies Inc. ("Saringer"). As previously reported on January 15, 2020 the Company entered into a non-binding letter of intent ("LOI") to acquire Benepod® pain relief technology and other medical device related technology from...
2020-04-08 9:26 AM EDT
Therma Bright Signs LOI to Acquire Benepod(R) Pain Relief Technology and Other Medical Device Technology from Saringer Life Science Technologies Inc.
Toronto, Ontario--(Newsfile Corp. - January 15, 2020) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, enters into a non-binding letter of intent ("LOI") to acquire Benepod® pain relief technology and other medical device related technology from Saringer Life Science Technologies Inc. ("Saringer" or "SLST Inc."). Therma is in the process of conducting due diligence on Saringer. The LOI contemplates that this transaction...
2020-01-15 9:46 AM EST
Therma Bright's International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada
Toronto, Ontario--(Newsfile Corp. - September 5, 2019) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, today announces that the TherOZap™ technology under the Company's former name, The Jenex Corporation, has filed an international patent application under the PCT convention for its thermal therapy TherOZap™ and has recently entered the national phases in the US, Europe and Canada. In the international phase, the international...
2019-09-05 6:30 AM EDT
TherOZap(TM) Technology Test Results Prove Successful at Inhibiting Zika Virus During In-Vitro Tests
Toronto, Ontario--(Newsfile Corp. - September 4, 2019) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, today announces that the TherOZap™ Technology proves successful at inhibiting the Zika virus during in-vitro tests. Therma engaged a top Virology Research Laboratory in Canada to study Therma's TherOZap™ technology's ability to inactivate live Zika virus in culture media and to determine inhibition of the Zika virus infection...
2019-09-04 6:30 AM EDT
Therma Bright Inc. Continues Testing of TherOZap(TM) Technology Against the Zika Virus
Toronto, Ontario--(Newsfile Corp. - July 3, 2019) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, is pleased to announce that further to its press releases on October 11th and December 17th, 2018 and March 28th, 2019 that the Company continues testing of the TherOZap™ technology against the Zika virus upon the advice of one of the top research laboratories in Canada working with Therma Bright. A number of additional...
2019-07-03 7:00 AM EDT
Therma Bright Inc. in Final Stages of Testing TherOZap(TM) Technology Against the Zika Virus
Toronto, Ontario--(Newsfile Corp. - March 28, 2019) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company is pleased to announce, further to the press releases on October 11th and December 17th, 2018, that the Company is in the final stages of in vitro testing and awaits the results of the TherOZap™ technology against the Zika virus. Testing is being conducted through a top research laboratory in Canada. The Company expects to...
2019-03-28 7:48 AM EDT
Therma Bright Inc. Issues Update on Pain Relief Device and TherOZap(TM) Technology
Toronto, Ontario--(Newsfile Corp. - December 18, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, today announces that it has received the prototype of its pain relief device and provides an update on its TherOZap™ technology. Therma Bright in October introduced the first design of its pain relief product for general, arthritic or orthopedic pain. Rapidly advancing its development, the Company has received the...
2018-12-18 8:30 AM EST
Therma Bright Inc. to Establish Subsidiary for Cannabis Related Devices
Toronto, Ontario--(Newsfile Corp. - November 1, 2018) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company announces that it will incorporate a 100% wholly owned subsidiary (the "Subsidiary") to hold device related technology for the application or use of medicinal or recreational marijuana. The Company plans to hold the pain relief device, as described in a press release on October 1st, and all related intellectual property...
2018-11-01 8:51 AM EDT
Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus
Toronto, Ontario--(Newsfile Corp. - October 11, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company announces, further to its press release on January 8, 2018 outlining results indicating effectiveness of its TherOZap™ technology at inhibiting the Zika virus, that the Company has engaged a top research laboratory made up of virology experts to further test the TherOZap™ technology against the Zika virus. The research...
2018-10-11 8:54 AM EDT
Therma Bright Provides Corporate Update on Pain Relief Device Incorporating Medicinal Cannabis, Further Testing of TherOZap(TM) Technology Against the Zika Virus and Finalizes Multi-Use Activators
Toronto, Ontario--(Newsfile Corp. - October 1, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, provides the following updates:Therma Bright Advances Design of Pain Relief Device Incorporating Medicinal Cannabis, CBD from Hemp and other Pain Relief formulations: Further to its press release on May 8th, 2018 Therma Bright is pleased to announce that after extensive consultation with designers and engineers the Company...
2018-10-01 9:10 AM EDT
Therma Bright Adds Strategic Advisor, Too Jae Min, Professor, Department of Anesthesiology and Pain Medicine, Korea University
Toronto, Ontario--(Newsfile Corp. - September 17, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright", "Therma", or the "Company"- formerly The Jenex Corporation), a progressive medical device technology company, today is pleased to announce the appointment of Dr. Too Jae Min, Professor, Department of Anesthesiology and Pain Medicine, Korea University. Therma Adds Advisory Board Member Dr. Too Jae Min: Dr. Too Jae Min has over 18 years experience in both academia and the business world...
2018-09-17 8:32 AM EDT
Therma Bright Announces 2nd Tranche Closing of Private Placement
Toronto, Ontario--(Newsfile Corp. - July 11, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, announces that it has now completed the second and final tranche closing of its equity private placement initially announced on April 19, 2018 and has issued 580,000 units. No finder's fee was paid with respect to this tranche closing. All securities issued in this second tranche closing are subject to a hold period expiring...
2018-07-11 8:00 AM EDT
Therma Bright Inc. Appoints New CFO
Toronto, Ontario--(Newsfile Corp. - July 6, 2018) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company, is pleased to announce the appointment of Victor Hugo as Chief Financial Officer (CFO) effective immediately. Mr. Victor Hugo is senior financial analyst at Marrelli Support Services Inc., providing CFO, accounting, regulatory compliance, and management advisory services to numerous issuers on the TSX, TSX Venture Exchange and...
2018-07-06 8:34 AM EDT
Therma Bright Inc. Adds Board Member, Provides Update and Option Grant
Toronto, Ontario--(Newsfile Corp. - June 19, 2018) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company, today is pleased to announce the appointment of Spencer Sung Bum Huh as Director. Spencer Sung Bum Huh, BEc.: Mr. Huh graduated from the Korea University in Seoul with a BEc. He is an experienced and proven financial professional with more than 25 years of financial and operational experience in Canada and Korea, and a track...
2018-06-19 10:15 AM EDT
Therma Bright Extends Closings of Financings
Toronto, Ontario--(Newsfile Corp. - June 11, 2018) - Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, announces that it is extending the closing date of its previously announced equity financing of up to $2.5 million and convertible debenture financing of up to $1.5 million, for a further thirty (30) days from the date of this release. This extension will provide investors additional time to complete and deliver their...
2018-06-11 5:30 PM EDT